Page
%P
-
Article
CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma
Patients with recurrent or refractory Hodgkin's and non-Hodgkin's lymphoma are increasingly being treated with high-dose therapy and hematopoietic cell transplantation. As minimal disease status at the time of...